miRaX Therapeutics K.K.
PrivateCompany Overview
miRaX Therapeutics K.K. is a biotechnology company that develops antisense oligonucleotide therapies based on microRNA silencing technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
antisense oligonucleotidemiRNAmiRNA inhibitionASOnucleic acid therapeuticssynthetic nucleic aciddrug discoveryRNA medicineRNAioncology therapeuticsfibrosis treatmentbiotech licensingpreclinical researchgene regulation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
miRaX Therapeutics K.K. Comparables
Compare miRaX Therapeutics K.K. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LigamiR Therapeutics | 80% | |
| Resalis Therapeutics | 78% | |
| Neumirna Therapeutics | 75% | |
miRaX Therapeutics K.K. Funding Rounds
Historical fundraising activity
miRaX Therapeutics K.K. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about miRaX Therapeutics K.K.'s valuation, stock price, and market status.
See something wrong or outdated?